80+
Companies
$12B+
Total Funding
5
Major Hubs
6
Public Companies

Greater Boston Biotech Hub

World's largest life sciences cluster with Harvard, MIT, and Wyss Institute innovation

FDA ISTAND

Emulate

Human Emulation System. Wyss Institute spinout. FDA ISTAND-qualified Liver-Chip. $225M+ raised.

Boston Series E
Flagship

Generate Biomedicines

Generative biology platform. Diffusion models for protein design. Flagship Pioneering company. $450M+ raised.

Cambridge Series C
NASDAQ: RLAY

Relay Therapeutics

Dynamo platform combining MD simulations and ML. Protein motion analysis for drug design.

Cambridge Public
Flagship

Valo Health

Opal computational platform. Clinical data analytics. Acquired Tara Biosystems. $500M+ raised.

Boston Series C

Draper Laboratory

PREDICT96 multi-tissue platform. Non-profit R&D organization. Government partnerships.

Cambridge Non-Profit

Javelin Biotech

Multiplexed organ-chip systems. MIT spinout. Single-cell resolution analytics.

Boston Seed

Bay Area & Silicon Valley

Tech-driven biotech combining AI, automation, and life sciences innovation

AI Leader

Insitro

ML for drug discovery. Founded by Daphne Koller. Roche, Gilead partnerships. $743M raised.

South SF Series C
Brain Organoids

System1 Biosciences

Vascularized brain organoids. UCSF spinout. Precision psychiatry platform.

San Francisco Series A

Aracari Biosciences

VascuLab platform. Vascularized tissue models with perfusable microvessels.

California Seed

Cureline

Human tissue collection and molecular services. Patient tissue procurement network.

Brisbane, CA Private

San Diego Biotech Cluster

Major life sciences hub with UCSD, Scripps, and Salk Institute connections

Pioneer

Organovo

3D bioprinting pioneer. ExVive liver and kidney tissues. Therapeutics focus. OTC: ONVO.

San Diego OTC Listed

Trestle Biotherapeutics

Bioengineered kidney tissue. UCSD spinout. Implantable renal tissue patches.

San Diego Series A

Advanced BioMatrix

Collagen-based bioinks and ECM products. LifeInk portfolio for tissue engineering.

San Diego Established

Canadian Innovation

Growing hub for biotech with strong university and government support

NASDAQ: ABCL

AbCellera

AI-powered antibody discovery. Single-cell technology. Discovered bamlanivimab. $600M+ raised.

Vancouver Public
Microfluidic

Aspect Biosystems

Microfluidic 3D bioprinting. J&J partnership for Type 1 diabetes. $140M+ raised.

Vancouver Series C

Phenomic AI

Cell morphology AI for drug discovery. Deep learning on cellular images. Montreal-based.

Montreal Series A

Explore Other Regions

Discover human simulation companies across global biotech hubs

Europe Asia-Pacific All Companies